Evidence map›Paper›PMID 42901597›Full record

ArticleBMJ open2026

Adverse oral effects of GLP-1 and GIP receptor agonists: a scoping review protocol.

Doménica Gabriela Escudero Samaniego, Melany Abigail Falconí Tarapués, Bianca Taíz Cañarte Vergara, Manuella Salm Coelho, Maria de Fátima De Magalhães Gonzaga, Cristine Miron Stefani, Thais Marques Simek Gonçalves, Graziela De Luca Canto, Patricia Pauletto

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Doménica Gabriela Escudero SamaniegoFaculty of Dentistry, Universidad de Las Americas Facultad de Ciencias de la Salud, Quito, Ecuador.ORCID http://orcid.org/0009-0008-6163-031X
Melany Abigail Falconí TarapuésFaculty of Dentistry, Universidad de Las Americas Facultad de Ciencias de la Salud, Quito, Ecuador.
Bianca Taíz Cañarte VergaraFaculty of Dentistry, Universidad de Las Americas Facultad de Ciencias de la Salud, Quito, Ecuador.
Manuella Salm CoelhoBrazilian Centre for Evidence-Based Research, Federal University of Santa Catarina, Florianópolis, Brazil.
Maria de Fátima De Magalhães GonzagaUniversity Hospital of Brasilia, University of Brasília, Brasília, Brazil.
Cristine Miron StefaniDepartment of Dentistry, University of Brasilia, Brasília, Brazil.
Thais Marques Simek GonçalvesDepartment of Dentistry, Federal University of Santa Catarina, Florianópolis, Brazil.
Graziela De Luca CantoBrazilian Centre for Evidence-Based Research, Federal University of Santa Catarina, Florianópolis, Brazil.
Patricia PaulettoFaculty of Dentistry, Universidad de Las Americas Facultad de Ciencias de la Salud, Quito, Ecuador patricia.pauletto@udla.edu.ec.ORCID http://orcid.org/0000-0002-1762-7059

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adverse eventsGlycemic ControlHealthMedication ReviewReview

Identifiers

PMID42901597
PMCPMC13684195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.